Pernet, Olivier
Weisenhaus, Maia
Stafylis, Chrysovalantis
Williams, Christopher
Campan, Mihaela
Pettersson, Jonas
Green, Nicole
Lee, David M.
Thomas, Paul D.
Ward, Pamela
Hu, Howard
Klausner, Jeffrey D.
Kovacs, Andrea A. Z.
,
Hernandez-Tamayo, Cassidy
Van Orman, Sarah
Gilliland, Frank
Conti, David
Ghanem-Uzqueda, Angie
Yepez, Daniel
Stellar, Sofia
Tadanki, Aditya P.
Max, Jillian
Fottrell, Honour
Ong, Ethan
Navarro, Sabrina
Moses, Kaelyn
Akaolisa, Michael
Hosseini, Bijan
Sunesara, Shaleen
Wang, Yuzhu
Zaw, Andrew
Strum, Earl
Casagrande, Yolee
Hernandez-Rodriguez, Nathalie
Thomas, Paul
Chu, Tara
Emerson, Jane
Funding for this research was provided by:
COVID-19 Keck Research Fund (22-2146-1306, 22-2146-1306, 22-2146-1306, 22-2146-1306, 22-2146-1306, 22-2146-1306, 22-2146-1306, 22-2146-1306, 22-2146-1306, 22-2146-1306, 22-2146-1306, 22-2146-1306, 22-2146-1306)
Article History
Received: 20 September 2022
Accepted: 25 April 2023
First Online: 10 May 2023
Competing interests
: OP is the CEO/President of EnViro International Laboratories, a non-profit organization working on emerging diseases and outbreak preparedness. OP does not receive any compensation in any form from EnViro International Laboratories. The other authors (MW, CS, CW, MC, JP, NG, DML, PDT, PW, HH, JDK, and AAZK) declared not competing interests.